These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2809479)

  • 21. Changes in the hypothalamo-corticotrope axis after bilateral adrenalectomy: evidence for a median eminence site of glucocorticoid action.
    Spinedi E; Giacomini M; Jacquier MC; Gaillard RC
    Neuroendocrinology; 1991 Feb; 53(2):160-70. PubMed ID: 1849620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acetylcholine and norepinephrine stimulate the release of corticotropin-releasing factor-41 from the rat hypothalamus in vitro.
    Tsagarakis S; Holly JM; Rees LH; Besser GM; Grossman A
    Endocrinology; 1988 Oct; 123(4):1962-9. PubMed ID: 2970959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of cyproheptadine on the release of corticotrophin releasing factor.
    Jones MT; Birmingham M; Gillham B; Holmes M; Smith T
    Clin Endocrinol (Oxf); 1979 Feb; 10(2):203-5. PubMed ID: 311717
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of atrial natriuretic peptide on acetylcholine-induced release of corticotropin-releasing factor from rat hypothalamus in vitro.
    Takao T; Hashimoto K; Ota Z
    Life Sci; 1988; 42(12):1199-203. PubMed ID: 2964553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuropeptide Y increases the corticotropin-releasing factor messenger ribonucleic acid level in the rat hypothalamus.
    Suda T; Tozawa F; Iwai I; Sato Y; Sumitomo T; Nakano Y; Yamada M; Demura H
    Brain Res Mol Brain Res; 1993 Jun; 18(4):311-5. PubMed ID: 8392133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Corticotropin-releasing factors (CRF) secreted by the rat median eminence in vitro in the presence or absence of ascorbic acid: quantitative role of vasopressin and catecholamines.
    Bény JL; Baertschi AJ
    Endocrinology; 1981 Sep; 109(3):813-7. PubMed ID: 6266808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blockade of alpha 2-adrenoceptors stimulates basal and stress-induced adrenocorticotropin secretion in the developing rat through a central mechanism independent from corticotropin-releasing factor and arginine vasopressin.
    Grino M; Paulmyer-Lacroix O; Faudon M; Renard M; Anglade G
    Endocrinology; 1994 Dec; 135(6):2549-57. PubMed ID: 7988443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin-2 (IL-2) induces corticotropin-releasing factor (CRF) release from the amygdala and involves a nitric oxide-mediated signaling; comparison with the hypothalamic response.
    Raber J; Koob GF; Bloom FE
    J Pharmacol Exp Ther; 1995 Feb; 272(2):815-24. PubMed ID: 7853199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In-vitro effects of corticosterone, synthetic ovine corticotrophin releasing factor and arginine vasopressin on the release of adrenocorticotrophin by fetal rat pituitary glands.
    Dupouy JP; Chatelain A
    J Endocrinol; 1984 Jun; 101(3):339-44. PubMed ID: 6327872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interferon-alpha and transforming growth factor-beta 1 regulate corticotropin-releasing factor release from the amygdala: comparison with the hypothalamic response.
    Raber J; Koob GF; Bloom FE
    Neurochem Int; 1997; 30(4-5):455-63. PubMed ID: 9106261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Valproic acid inhibits corticotropin-releasing factor synthesis and release from the rat hypothalamus in vitro: evidence for the involvement of GABAergic neurotransmission.
    Tringali G; Aubry JM; Moscianese K; Zamori C; Vairano M; Preziosi P; Navarra P; Pozzoli G
    J Psychiatry Neurosci; 2004 Nov; 29(6):459-66. PubMed ID: 15644987
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction between prolactin and catecholamines on hypothalamic GnRH release in vitro.
    Calogero AE; Burrello N; Ossino AM; Weber RF; D'Agata R
    J Endocrinol; 1996 Nov; 151(2):269-75. PubMed ID: 8958787
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arginine vasopressin is a much more potent stimulus to ACTH release from ovine anterior pituitary cells than ovine corticotropin-releasing factor. 1. In vitro studies.
    Familari M; Smith AI; Smith R; Funder JW
    Neuroendocrinology; 1989 Aug; 50(2):152-7. PubMed ID: 2550836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Norepinephrine but not epinephrine stimulates the release of corticotropin-releasing factor from in vitro superfused rat hypothalamus.
    Orliaguet G; Mélik Parsadaniantz S; Lenoir V; Duval P; Kerdelhué B
    J Neurosci Res; 1995 Oct; 42(2):236-41. PubMed ID: 8568924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Different gamma-aminobutyric acid receptor subtypes are involved in the regulation of opiate-dependent and independent luteinizing hormone-releasing hormone secretion.
    Masotto C; Wisniewski G; Negro-Vilar A
    Endocrinology; 1989 Jul; 125(1):548-53. PubMed ID: 2544412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies of the secretion of corticotropin-releasing factor and arginine vasopressin into the hypophysial-portal circulation of the conscious sheep. I. Effect of an audiovisual stimulus and insulin-induced hypoglycemia.
    Engler D; Pham T; Fullerton MJ; Ooi G; Funder JW; Clarke IJ
    Neuroendocrinology; 1989 Apr; 49(4):367-81. PubMed ID: 2541360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NPY Y1 receptors exert opposite effects on corticotropin releasing factor and noradrenaline overflow from the rat hypothalamus in vitro.
    Hastings JA; McClure-Sharp JM; Morris MJ
    Brain Res; 2001 Jan; 890(1):32-7. PubMed ID: 11164766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of corticotrophin-releasing hormone, arginine vasopressin and their antagonists on ACTH release from perifused horse anterior pituitary cells.
    Ellis MJ; Mulligan RS; Evans MJ; Donald RA
    J Endocrinol; 1994 Oct; 143(1):85-93. PubMed ID: 7964325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Corticotropin-releasing factor release from in vitro superfused and incubated rat hypothalamus. Effect of potassium, norepinephrine, and dopamine.
    Joanny P; Steinberg J; Zamora AJ; Conte-Devolx B; Millet Y; Oliver C
    Peptides; 1989; 10(5):903-11. PubMed ID: 2514417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of excitatory amino acid transmitters on hypothalamic corticotropin-releasing hormone (CRH) and arginine-vasopressin (AVP) release in vitro: implications in pituitary-adrenal regulation.
    Patchev VK; Karalis K; Chrousos GP
    Brain Res; 1994 Jan; 633(1-2):312-6. PubMed ID: 7907936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.